Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment
- 23 January 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 53 (8), 967-977
- https://doi.org/10.1007/s00535-018-1434-6
Abstract
Type 1 autoimmune pancreatitis (AIP), as a pancreatic manifestation of IgG4-related disease, shows a favorable prognosis in the short term. However, disease relapse is common in long-term follow-up, despite a successful initial treatment response. This study aimed to identify the predictors of relapse and long-term outcomes in patients with type 1 AIP.Keywords
This publication has 39 references indexed in Scilit:
- Recent advances in autoimmune pancreatitis: type 1 and type 2Gut, 2013
- International Consensus Diagnostic Criteria for Autoimmune PancreatitisPancreas, 2011
- The need for a consensus on the definition of remission of autoimmune pancreatitis after steroid treatmentGut, 2010
- Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitisGastrointestinal Endoscopy, 2010
- Presentation and Management of Post-treatment Relapse in Autoimmune Pancreatitis/Immunoglobulin G4-Associated CholangitisClinical Gastroenterology and Hepatology, 2009
- Standard steroid treatment for autoimmune pancreatitisGut, 2009
- Autoimmune Pancreatitis, Part II: The RelapseGastroenterology, 2008
- Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatmentGut, 2007
- Clinical features of autoimmune pancreatitisThe Esophagus, 2007
- High Serum IgG4 Concentrations in Patients with Sclerosing PancreatitisThe New England Journal of Medicine, 2001